This document discusses herbal cosmetics and the raw materials used in their production. It defines herbal cosmetics as cosmetic formulations containing one or more ingredients of natural origin. Some key raw materials discussed include oils from plants like coconut, olive and sunflower. Herbs and plant extracts used include aloe vera, neem, turmeric and green tea. Herbal cosmetics are classified into skin care products, hair care products and oral care products. Important herbal ingredients for skin care discussed are coconut oil, aloe vera and turmeric. For hair care, key herbs mentioned are amla, henna, brahmi and methi. The document highlights the advantages of herbal cos
This document provides information about the nutraceutical properties of various herbs and foods. It discusses the health benefits of nutraceuticals in treating diseases like diabetes, cardiovascular diseases, cancer, and gastrointestinal issues. Key points covered include the classification of nutraceuticals, probiotics and prebiotics, polyunsaturated fatty acids, vitamins, and the traditional and global market of nutraceuticals. Specific herbs discussed include alfalfa, chicory, ginger, fenugreek, garlic, and honey.
Herbs, Herbal Drugs
Present Scope of Herbal Drug Industry
Scope of Herbal Drug Medicine and Industry
Indian Herbal Industry
International Scope of Herbal Medicines
World Wide Herbal Trade
Overview on plant based industries and research institutions in India
List of few herbal drug industries in India
List of few herbal research institution/ centres in India
General Introduction to Herbal Industry
Herbal drugs industry: Present scope and future prospects.
A brief account of plant based industries and institutions involved in work on medicinal and
aromatic plants in India.
The document outlines the regulatory framework for Ayurvedic, Siddha, and Unani (ASU) drugs in India. It discusses the need for drug regulations to ensure safety, quality and promote public health. Key regulatory bodies like the ASU Drugs Technical Advisory Board and Drugs Consultative Committees are described. Manufacturing of ASU drugs must follow good manufacturing practices and adhere to standards for hygienic facilities, equipment and record keeping. The sale of adulterated, misbranded or prohibited drugs is penalized under the Drugs and Cosmetics Act.
The document discusses the Good Manufacturing Practices (GMP) guidelines for Ayurvedic, Siddha, and Unani medicines as specified in Schedule T of the Drugs and Cosmetics Rules. It covers various components of GMP including factory premises requirements, machinery and equipment, production areas, raw material and finished goods storage, worker hygiene, and documentation. The objective of GMP is to ensure quality control throughout the manufacturing process to produce medicines of acceptable standards.
Quality control test: Containers, Closures and Secondary packing materialsPranali Polshettiwar
This document summarizes quality control tests for containers, closures, and secondary packaging materials. It describes common materials used for each, such as glass, plastic, metal for containers and rubber, plastic, metal for closures. Key quality tests for containers include powdered glass test, water attack test, hydrolytic resistance test, and thermal shock test. Tests for closures include residue on evaporation, pH of extract, and sterility. Secondary packaging materials like paper and cardboard are also tested for quality.
This document discusses herbal cosmetics and the raw materials used in their production. It defines herbal cosmetics as cosmetic formulations containing one or more ingredients of natural origin. Some key raw materials discussed include oils from plants like coconut, olive and sunflower. Herbs and plant extracts used include aloe vera, neem, turmeric and green tea. Herbal cosmetics are classified into skin care products, hair care products and oral care products. Important herbal ingredients for skin care discussed are coconut oil, aloe vera and turmeric. For hair care, key herbs mentioned are amla, henna, brahmi and methi. The document highlights the advantages of herbal cos
This document provides information about the nutraceutical properties of various herbs and foods. It discusses the health benefits of nutraceuticals in treating diseases like diabetes, cardiovascular diseases, cancer, and gastrointestinal issues. Key points covered include the classification of nutraceuticals, probiotics and prebiotics, polyunsaturated fatty acids, vitamins, and the traditional and global market of nutraceuticals. Specific herbs discussed include alfalfa, chicory, ginger, fenugreek, garlic, and honey.
Herbs, Herbal Drugs
Present Scope of Herbal Drug Industry
Scope of Herbal Drug Medicine and Industry
Indian Herbal Industry
International Scope of Herbal Medicines
World Wide Herbal Trade
Overview on plant based industries and research institutions in India
List of few herbal drug industries in India
List of few herbal research institution/ centres in India
General Introduction to Herbal Industry
Herbal drugs industry: Present scope and future prospects.
A brief account of plant based industries and institutions involved in work on medicinal and
aromatic plants in India.
The document outlines the regulatory framework for Ayurvedic, Siddha, and Unani (ASU) drugs in India. It discusses the need for drug regulations to ensure safety, quality and promote public health. Key regulatory bodies like the ASU Drugs Technical Advisory Board and Drugs Consultative Committees are described. Manufacturing of ASU drugs must follow good manufacturing practices and adhere to standards for hygienic facilities, equipment and record keeping. The sale of adulterated, misbranded or prohibited drugs is penalized under the Drugs and Cosmetics Act.
The document discusses the Good Manufacturing Practices (GMP) guidelines for Ayurvedic, Siddha, and Unani medicines as specified in Schedule T of the Drugs and Cosmetics Rules. It covers various components of GMP including factory premises requirements, machinery and equipment, production areas, raw material and finished goods storage, worker hygiene, and documentation. The objective of GMP is to ensure quality control throughout the manufacturing process to produce medicines of acceptable standards.
Quality control test: Containers, Closures and Secondary packing materialsPranali Polshettiwar
This document summarizes quality control tests for containers, closures, and secondary packaging materials. It describes common materials used for each, such as glass, plastic, metal for containers and rubber, plastic, metal for closures. Key quality tests for containers include powdered glass test, water attack test, hydrolytic resistance test, and thermal shock test. Tests for closures include residue on evaporation, pH of extract, and sterility. Secondary packaging materials like paper and cardboard are also tested for quality.
The document summarizes regulations for the manufacture and sale of Ayurvedic, Siddha, and Unani (ASU) drugs under Schedule Z of the Drugs and Cosmetics Act. It outlines requirements for factory premises including hygienic conditions. It also prohibits the manufacture and sale of certain misbranded, adulterated, or spurious ASU drugs. Penalties are prescribed for contraventions including imprisonment and fines. The central government can prohibit ASU drugs if they pose risks or do not have claimed therapeutic value. Separate licenses are needed if manufacturing occurs at multiple premises.
This document discusses herbal formulations, including types such as herbal syrups, herbal mixtures, and tablets. It provides details on preparing herbal syrups, including using equal proportions of herbal infusions/decoctions and honey or sugar. Advantages of herbal syrups include masking bad tastes and soothing irritated tissues. The document also discusses novel herbal dosage forms like phytosomes, which are complexes of herbal extracts and phospholipids that can enhance absorption and bioavailability. Methods of preparing phytosomes and evaluating their properties and advantages are provided.
The document discusses regulations for herbal medicines in India. It notes that herbal medicines, also known as Ayurvedic, Siddha, and Unani (ASU) medicines, are regulated under the Drugs and Cosmetics Act of 1940 and Rules of 1945. The Ministry of AYUSH is the regulatory authority that oversees licensing for manufacturing and marketing of herbal drugs. ASU medicines are considered safe due to their long history of use in India, so no safety or efficacy studies are required for approval. However, standardization of raw materials is a key issue given potential for contamination. The Drug Technical Advisory Board and Drug Consultative Committee provide regulatory oversight of the herbal drug sector.
Herb drug and herb food interaction ppt by nitesh kumarNITESH KUMAR
HERB DRUG AND HERB FOOD INTERACTION IS AN IMPORTANT CHAPTER IN HERBLA DRUG TECHNOLOGY IN THE SYLLABUS OF B.PHARMACY 6TH SEM. IT GIVES A BETTER UNDERTANDING OF HERB FOOD INTERACTION AND RELATED DRUGS.
The document discusses biodynamic agriculture, which is a form of organic farming developed by Rudolf Steiner. It treats soil, plants, and livestock as an interconnected ecological system. Biodynamic farming uses techniques like composting, crop rotation, and integrating natural pest predators. The document also provides guidelines for good agricultural practices in cultivating medicinal plants, covering topics from seed sourcing to harvesting, processing, packaging, and storage. It discusses integrated pest management using mechanical, biological, and chemical methods, with an emphasis on biopesticides that control pests naturally without toxic residues.
The document discusses various herbal excipients that can be used in pharmaceutical formulations. It describes natural colorants, sweeteners, and binding agents that are derived from plant sources. Some key points discussed include natural colorants like henna, turmeric, and saffron; sweeteners such as stevia, licorice root, and bitter orange; and binding agents including acacia, tragacanth, and various plant gums. The document emphasizes the advantages of herbal excipients like low toxicity, biodegradability, availability, and low cost. It provides details on the plant source, active compounds, and uses of some important natural excipients.
This document outlines World Health Organization (WHO) and International Council for Harmonization (ICH) guidelines for evaluating herbal drugs. It discusses evaluating the quality, safety, efficacy and intended use of herbal medicines according to WHO guidelines. This includes assessing the botanical identity and constituents of plant materials, manufacturing processes, stability testing, safety, efficacy based on literature and traditional use, and providing product information for consumers. ICH guidelines on quality and safety are also used to assess drug substances. The overall aim is to help regulatory authorities and manufacturers properly evaluate herbal drugs.
Bioavailability is defined as the rate and extent of absorption of a drug from its dosage form and the amount available at the site of action. It depends on pharmaceutical, patient, and route of administration factors. The objectives of bioavailability studies are to develop new formulations, determine the influence of excipients and other drugs, and control drug product quality. Bioavailability can be assessed using pharmacokinetic methods like plasma concentration-time profiles from single and multiple dose studies, and urinary excretion studies. Key parameters analyzed are Cmax, Tmax, and AUC which indicate rate and extent of absorption. Pharmacodynamic methods like acute pharmacological response and therapeutic response studies can also be used when pharmacokinetic methods are not suitable. In
It is unique in bringing together the regulatory authorities and
pharmaceutical industry to discuss scientific and technical aspects of pharmaceuticals and develop ICH guidelines.
Regulations in India (ASU DTAB, ASU DCC), Regulation of
manufacture of ASU drugs - Schedule Z of Drugs & Cosmetics Act for ASU drugs.
Introduction
Regulatory Requirements
Key function of regulatory agencies
Regulation in India
DRUG TECHNICAL ADVISORY BOARD
Drugs Consultative committee-DCC
Schedule Z of Drugs & Cosmetics Act for ASU drugs.
Herbal excipients are non-active ingredients used in herbal medicines that help process, protect, support, enhance stability or patient acceptability of the active compounds. The document discusses various types of herbal excipients including colorants, sweeteners, binders, diluents, viscosity enhancers, disintegrants and flavors. For each type, examples of specific herbal sources are provided, including the plant name and family as well as the active constituent. Advantages and disadvantages of using herbal excipients are also summarized.
The document discusses regulatory issues related to Ayurvedic, Siddha, and Unani (ASU) drugs in India. It provides information on the regulatory bodies that govern ASU drugs, including the Drug Technical Advisory Board (DTAB) and Drugs Consultative Committee (DCC). It also outlines regulations for the manufacture of ASU drugs, including Schedule Z of the Drugs and Cosmetics Act and Schedule T which specifies good manufacturing practices.
Absorption of drugs from non per os extravascular administrationSuvarta Maru
Non-oral routes of drug administration provide advantages over oral routes by bypassing the gastrointestinal tract and avoiding first-pass metabolism. Common non-oral routes discussed include buccal/sublingual, rectal, topical, intramuscular, subcutaneous, pulmonary, intranasal, intraocular, and vaginal administration. Absorption through these routes occurs primarily via passive diffusion, carrier-mediated transport, or pore transport depending on the drug properties and administration site. Non-oral routes allow for rapid drug absorption, higher bioavailability compared to oral routes, and targeted delivery for local or systemic effects.
Definition of drug interaction, potential of herb-drug interactions,significance of study of herb-drug interactions, reasons for their study, types according to ayurveda, effects & different ways of herb-drug interactions, their mechanism, hypericum, kava lava, ginkgo biloba, ginseng, garlic, pepper, ephedra.
This document discusses herb-food and herb-drug interactions. It defines an interaction as an alteration in a drug's effects caused by another substance. There are several types of interactions, including drug-drug, drug-food, and drug-disease. Herb-drug interactions can occur through pharmacodynamic or pharmacokinetic mechanisms. Pharmacodynamic interactions involve effects at receptor sites, while pharmacokinetic interactions affect absorption, distribution, metabolism, or excretion of drugs. Many herbs can interact with prescription medications in dangerous ways. Lack of knowledge, quality control, and research contribute to risks of herb-drug interactions.
This document outlines good manufacturing practices (GMP) for Ayurvedic, Siddha, and Unani medicines. It discusses infrastructure requirements for manufacturing facilities, including adequate space for receiving raw materials, manufacturing, quality control, finished goods storage, and offices. It also covers requirements for buildings, water supply, waste disposal, cleaning of containers, storage, and machinery/equipment. Worker health, clothing, sanitation, and medical services are also addressed. The objective is to ensure raw materials are authentic and contamination-free, manufacturing follows the proper process, quality control measures are in place, and the finished drug is of acceptable quality.
Herbal Drug Technology (B.Pharm. 6th Semester)
Definition of herbs, herbal medicine, herbal medicinal product, herbal drug preparation
Source of herbs, Selection, identification and authentication of herbal materials,
Processing of herbal raw material
This document provides an overview of herbal drug technology and the Indian system of medicine. It discusses herbs as raw materials, including their definition and uses. It also covers biodynamic agriculture principles and Good Agricultural Practices for cultivating medicinal plants. The document discusses various processing steps for herbal raw materials. It provides details on the Ayurveda and Siddha systems of traditional Indian medicine, including their basic principles and approaches to treatment. Pest control methods for medicinal plants are also summarized, including the use of biopesticides derived from plants.
This document discusses irritable bowel syndrome (IBS) and the role of diet. It begins by defining IBS and outlining the Rome III criteria used for diagnosis. It describes symptoms like diarrhea, constipation, abdominal pain that are relieved by defecation. It discusses triggers for IBS like certain foods, caffeine, food dyes, MSG that can cause diarrhea. The document presents a case study of a patient who found significant relief of IBS symptoms by eliminating trigger foods. It also summarizes that traditional drug therapies only treat symptoms, not underlying causes, and that food intolerance can be an important factor in IBS for some patients.
The document summarizes regulations for the manufacture and sale of Ayurvedic, Siddha, and Unani (ASU) drugs under Schedule Z of the Drugs and Cosmetics Act. It outlines requirements for factory premises including hygienic conditions. It also prohibits the manufacture and sale of certain misbranded, adulterated, or spurious ASU drugs. Penalties are prescribed for contraventions including imprisonment and fines. The central government can prohibit ASU drugs if they pose risks or do not have claimed therapeutic value. Separate licenses are needed if manufacturing occurs at multiple premises.
This document discusses herbal formulations, including types such as herbal syrups, herbal mixtures, and tablets. It provides details on preparing herbal syrups, including using equal proportions of herbal infusions/decoctions and honey or sugar. Advantages of herbal syrups include masking bad tastes and soothing irritated tissues. The document also discusses novel herbal dosage forms like phytosomes, which are complexes of herbal extracts and phospholipids that can enhance absorption and bioavailability. Methods of preparing phytosomes and evaluating their properties and advantages are provided.
The document discusses regulations for herbal medicines in India. It notes that herbal medicines, also known as Ayurvedic, Siddha, and Unani (ASU) medicines, are regulated under the Drugs and Cosmetics Act of 1940 and Rules of 1945. The Ministry of AYUSH is the regulatory authority that oversees licensing for manufacturing and marketing of herbal drugs. ASU medicines are considered safe due to their long history of use in India, so no safety or efficacy studies are required for approval. However, standardization of raw materials is a key issue given potential for contamination. The Drug Technical Advisory Board and Drug Consultative Committee provide regulatory oversight of the herbal drug sector.
Herb drug and herb food interaction ppt by nitesh kumarNITESH KUMAR
HERB DRUG AND HERB FOOD INTERACTION IS AN IMPORTANT CHAPTER IN HERBLA DRUG TECHNOLOGY IN THE SYLLABUS OF B.PHARMACY 6TH SEM. IT GIVES A BETTER UNDERTANDING OF HERB FOOD INTERACTION AND RELATED DRUGS.
The document discusses biodynamic agriculture, which is a form of organic farming developed by Rudolf Steiner. It treats soil, plants, and livestock as an interconnected ecological system. Biodynamic farming uses techniques like composting, crop rotation, and integrating natural pest predators. The document also provides guidelines for good agricultural practices in cultivating medicinal plants, covering topics from seed sourcing to harvesting, processing, packaging, and storage. It discusses integrated pest management using mechanical, biological, and chemical methods, with an emphasis on biopesticides that control pests naturally without toxic residues.
The document discusses various herbal excipients that can be used in pharmaceutical formulations. It describes natural colorants, sweeteners, and binding agents that are derived from plant sources. Some key points discussed include natural colorants like henna, turmeric, and saffron; sweeteners such as stevia, licorice root, and bitter orange; and binding agents including acacia, tragacanth, and various plant gums. The document emphasizes the advantages of herbal excipients like low toxicity, biodegradability, availability, and low cost. It provides details on the plant source, active compounds, and uses of some important natural excipients.
This document outlines World Health Organization (WHO) and International Council for Harmonization (ICH) guidelines for evaluating herbal drugs. It discusses evaluating the quality, safety, efficacy and intended use of herbal medicines according to WHO guidelines. This includes assessing the botanical identity and constituents of plant materials, manufacturing processes, stability testing, safety, efficacy based on literature and traditional use, and providing product information for consumers. ICH guidelines on quality and safety are also used to assess drug substances. The overall aim is to help regulatory authorities and manufacturers properly evaluate herbal drugs.
Bioavailability is defined as the rate and extent of absorption of a drug from its dosage form and the amount available at the site of action. It depends on pharmaceutical, patient, and route of administration factors. The objectives of bioavailability studies are to develop new formulations, determine the influence of excipients and other drugs, and control drug product quality. Bioavailability can be assessed using pharmacokinetic methods like plasma concentration-time profiles from single and multiple dose studies, and urinary excretion studies. Key parameters analyzed are Cmax, Tmax, and AUC which indicate rate and extent of absorption. Pharmacodynamic methods like acute pharmacological response and therapeutic response studies can also be used when pharmacokinetic methods are not suitable. In
It is unique in bringing together the regulatory authorities and
pharmaceutical industry to discuss scientific and technical aspects of pharmaceuticals and develop ICH guidelines.
Regulations in India (ASU DTAB, ASU DCC), Regulation of
manufacture of ASU drugs - Schedule Z of Drugs & Cosmetics Act for ASU drugs.
Introduction
Regulatory Requirements
Key function of regulatory agencies
Regulation in India
DRUG TECHNICAL ADVISORY BOARD
Drugs Consultative committee-DCC
Schedule Z of Drugs & Cosmetics Act for ASU drugs.
Herbal excipients are non-active ingredients used in herbal medicines that help process, protect, support, enhance stability or patient acceptability of the active compounds. The document discusses various types of herbal excipients including colorants, sweeteners, binders, diluents, viscosity enhancers, disintegrants and flavors. For each type, examples of specific herbal sources are provided, including the plant name and family as well as the active constituent. Advantages and disadvantages of using herbal excipients are also summarized.
The document discusses regulatory issues related to Ayurvedic, Siddha, and Unani (ASU) drugs in India. It provides information on the regulatory bodies that govern ASU drugs, including the Drug Technical Advisory Board (DTAB) and Drugs Consultative Committee (DCC). It also outlines regulations for the manufacture of ASU drugs, including Schedule Z of the Drugs and Cosmetics Act and Schedule T which specifies good manufacturing practices.
Absorption of drugs from non per os extravascular administrationSuvarta Maru
Non-oral routes of drug administration provide advantages over oral routes by bypassing the gastrointestinal tract and avoiding first-pass metabolism. Common non-oral routes discussed include buccal/sublingual, rectal, topical, intramuscular, subcutaneous, pulmonary, intranasal, intraocular, and vaginal administration. Absorption through these routes occurs primarily via passive diffusion, carrier-mediated transport, or pore transport depending on the drug properties and administration site. Non-oral routes allow for rapid drug absorption, higher bioavailability compared to oral routes, and targeted delivery for local or systemic effects.
Definition of drug interaction, potential of herb-drug interactions,significance of study of herb-drug interactions, reasons for their study, types according to ayurveda, effects & different ways of herb-drug interactions, their mechanism, hypericum, kava lava, ginkgo biloba, ginseng, garlic, pepper, ephedra.
This document discusses herb-food and herb-drug interactions. It defines an interaction as an alteration in a drug's effects caused by another substance. There are several types of interactions, including drug-drug, drug-food, and drug-disease. Herb-drug interactions can occur through pharmacodynamic or pharmacokinetic mechanisms. Pharmacodynamic interactions involve effects at receptor sites, while pharmacokinetic interactions affect absorption, distribution, metabolism, or excretion of drugs. Many herbs can interact with prescription medications in dangerous ways. Lack of knowledge, quality control, and research contribute to risks of herb-drug interactions.
This document outlines good manufacturing practices (GMP) for Ayurvedic, Siddha, and Unani medicines. It discusses infrastructure requirements for manufacturing facilities, including adequate space for receiving raw materials, manufacturing, quality control, finished goods storage, and offices. It also covers requirements for buildings, water supply, waste disposal, cleaning of containers, storage, and machinery/equipment. Worker health, clothing, sanitation, and medical services are also addressed. The objective is to ensure raw materials are authentic and contamination-free, manufacturing follows the proper process, quality control measures are in place, and the finished drug is of acceptable quality.
Herbal Drug Technology (B.Pharm. 6th Semester)
Definition of herbs, herbal medicine, herbal medicinal product, herbal drug preparation
Source of herbs, Selection, identification and authentication of herbal materials,
Processing of herbal raw material
This document provides an overview of herbal drug technology and the Indian system of medicine. It discusses herbs as raw materials, including their definition and uses. It also covers biodynamic agriculture principles and Good Agricultural Practices for cultivating medicinal plants. The document discusses various processing steps for herbal raw materials. It provides details on the Ayurveda and Siddha systems of traditional Indian medicine, including their basic principles and approaches to treatment. Pest control methods for medicinal plants are also summarized, including the use of biopesticides derived from plants.
This document discusses irritable bowel syndrome (IBS) and the role of diet. It begins by defining IBS and outlining the Rome III criteria used for diagnosis. It describes symptoms like diarrhea, constipation, abdominal pain that are relieved by defecation. It discusses triggers for IBS like certain foods, caffeine, food dyes, MSG that can cause diarrhea. The document presents a case study of a patient who found significant relief of IBS symptoms by eliminating trigger foods. It also summarizes that traditional drug therapies only treat symptoms, not underlying causes, and that food intolerance can be an important factor in IBS for some patients.
Irritable Bowel Syndrome (IBS) is a functional bowel disorder that affects around 20% of the population. It is characterized by abdominal pain associated with changes in bowel habits and is more common in young females. IBS has no identifiable organic cause but involves low-grade inflammation, altered gut motility and microbiota, visceral hypersensitivity, and psychological factors like stress and anxiety. Treatment focuses on diet modification, fiber supplementation, antispasmodics, antidepressants, and psychological therapies depending on symptoms of diarrhea, constipation or pain.
Why Does My Stomach Ache? - Dennis Han, MD, Gastroenterologist - Morristown &...Summit Health
Do you have stomach issues which are bothering you and you can't figure out why? Learn about conditions that could be causing abdominal pain or discomfort at this virtual program. Our expert will discuss different conditions such as: Irritable Bowel Syndrome; Inflammatory Bowel Disease; Celiac Disease and other conditions that require a gluten-free diet; and GERD (Reflux). He will explain the differences between these various conditions, how they are diagnosed, and treatment options available. Hosted by Morristown & Morris Township Public Library.
This document discusses eating disorders such as anorexia nervosa, bulimia nervosa, binge eating disorder, rumination disorder, pica, and avoidant/restrictive food intake disorder. It provides facts about prevalence, symptoms, complications, etiology, medical and psychological treatment options. Common nursing diagnoses for patients with eating disorders include imbalanced nutrition, deficient fluid volume, anxiety, and disturbed body image/low self-esteem. Nursing interventions focus on monitoring intake/output, managing nutrition and hydration, providing support and education, and helping patients develop a healthy body image and coping strategies.
10 Common Digestive Problems and How to Deal with ThemNu U Nutrition
10 of the most common digestive issues faced in western society and how to address them, through diet, lifestyle changes, supplementation, and support from your doctor.
The document discusses the differences between food allergies and food intolerances. Food allergies involve an immune system response, while food intolerances do not. Common symptoms of food intolerances include bloating, gas, and abdominal discomfort. Food intolerances are often caused by a lack of enzymes to digest certain foods, food chemicals like histamine and salicylates, or pharmacological reactions. Diagnosis involves an elimination diet to identify trigger foods and improvement of symptoms when those foods are avoided.
This document provides an overview of irritable bowel syndrome (IBS), including its definition, prevalence, demographics, pathophysiology, clinical features, diagnosis, differential diagnosis, severity assessment, management, and prognosis. Some key points are:
- IBS is a functional bowel disorder characterized by abdominal pain associated with changes in bowel habits. It predominantly affects those aged 15-65 and is more common in women.
- The pathophysiology involves altered gut motility, visceral hypersensitivity, abnormal gas handling, low-grade inflammation, food sensitivities, abnormal gut microbiota, and central nervous system dysregulation.
- Diagnosis is based on symptoms meeting certain criteria and exclusion of organic diseases. Management focuses on
April is IBS Awareness Month. This presentation provides education on IBS symptoms, potential causes, medications and laboratory testing to determine if IBS is the issue.
The document discusses eating disorders, defining them as severe behavioral conditions characterized by disturbances in eating behaviors and associated distress. It outlines the main types of eating disorders like anorexia nervosa, bulimia nervosa, and binge eating disorder. Symptoms are described as alterations in weight, body image issues, disrupted eating patterns, and mood fluctuations. Causes may include genetics, biology, psychological factors like low self-esteem, and emotional health issues. Prevention and treatment involves healthy eating, medications, and psychological therapies like CBT and family therapy.
Eating disorders ( Anorexia nervosa and Bulimia nervosa)kalyan kumar
Eating disorders are a range of psychological conditions that cause unhealthy eating habits to develop. They might start with an obsession with food, body weight, or body shape.
In severe cases, eating disorders can cause serious health consequences and may even result in death if left untreated.
This document discusses recurrent abdominal pain in childhood and adolescence. It notes that recurrent abdominal pain (RAP) represents a description of symptoms, not a diagnosis, and is often caused by a functional gastrointestinal disorder (FGID). The four major pediatric disorders associated with RAP are functional abdominal pain syndrome, functional dyspepsia, irritable bowel syndrome, and abdominal migraine. A FGID is diagnosed using Rome criteria and treatment focuses on environmental modification, diet, and medication to manage symptoms.
This document provides information on functional bowel disorders and gastroparesis. It begins with an overview of functional bowel disorders, noting they refer to disorders of gut function without obvious structural abnormalities. It then discusses the Rome IV diagnostic criteria for functional gastrointestinal disorders, which categorizes them into several classes including esophageal, gastroduodenal, bowel, and anorectal disorders. Specific disorders like irritable bowel syndrome, functional dyspepsia, and rumination syndrome are defined. The document then focuses on gastroparesis, defining it as delayed gastric emptying without mechanical obstruction. It discusses the difference between functional dyspepsia and gastroparesis, classifications, epidemiology, etiology, predictive factors, typical presentation,
The document discusses irritable bowel syndrome (IBS), including its diagnostic criteria, clinical features, pathophysiology, and management. IBS is a functional bowel disorder characterized by abdominal pain and changes in bowel habits. It affects more females than males and typically presents before age 45. Key symptoms include crampy abdominal pain relieved by defecation and altered bowel habits with constipation or diarrhea. Treatment focuses on lifestyle modifications, diet changes, and medications to target specific IBS subtypes.
1. Irritable bowel syndrome (IBS) is a chronic functional gastrointestinal disorder characterized by abdominal pain and changes in bowel habits without any detectable organic cause.
2. IBS has no known underlying pathology but is associated with alterations in gut motility, sensitivity, and brain-gut interactions.
3. Treatment aims to manage individual symptoms and typically involves dietary changes, antidiarrheals, antispasmodics, antidepressants, and cognitive-behavioral therapy. Lifestyle management and stress reduction are also important aspects of treatment.
Similar to Nutraceutical in Irritable bowel syndrome (IBS) (20)
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
Basavarajeeyam is a Sreshta Sangraha grantha (Compiled book ), written by Neelkanta kotturu Basavaraja Virachita. It contains 25 Prakaranas, First 24 Chapters related to Rogas& 25th to Rasadravyas.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of the physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar lead (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
6. Describe the flow of current around the heart during the cardiac cycle
7. Discuss the placement and polarity of the leads of electrocardiograph
8. Describe the normal electrocardiograms recorded from the limb leads and explain the physiological basis of the different records that are obtained
9. Define mean electrical vector (axis) of the heart and give the normal range
10. Define the mean QRS vector
11. Describe the axes of leads (hexagonal reference system)
12. Comprehend the vectorial analysis of the normal ECG
13. Determine the mean electrical axis of the ventricular QRS and appreciate the mean axis deviation
14. Explain the concepts of current of injury, J point, and their significance
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. Chapter 3, Cardiology Explained, https://www.ncbi.nlm.nih.gov/books/NBK2214/
7. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxwalterHu5
In some case, your chronic prostatitis may be related to over-masturbation. Generally, natural medicine Diuretic and Anti-inflammatory Pill can help mee get a cure.
Rasamanikya is a excellent preparation in the field of Rasashastra, it is used in various Kushtha Roga, Shwasa, Vicharchika, Bhagandara, Vatarakta, and Phiranga Roga. In this article Preparation& Comparative analytical profile for both Formulationon i.e Rasamanikya prepared by Kushmanda swarasa & Churnodhaka Shodita Haratala. The study aims to provide insights into the comparative efficacy and analytical aspects of these formulations for enhanced therapeutic outcomes.
2. Content
• Introduction to nutraceuticals
• Introduction to IBS
• Causes
• Symptoms
• Role of nutraceuticals
• Reference
3. Introduction to Nutraceuticals
Nutraceutical Product –
Nutraceutical Product is a
food product that only supplements the diet but
also assists in treating or preventive diseases so
provides medical benefits
Eg. Citrus fruits ,milk, Vitamins
4. Irritable bowel syndrome
It tends to be an umbrella term for a verity of minor
bowel and disturbances of unknown origin
Irritable bowel syndrome is not a disease, it is a
functional disorder which means bowel simply does not
work as it should
sometimes called as
-Irritable colon
- Spastic Colon
5. Causes
o Abnormal Gastrointestinal tract movements
o Dietary allergy or food sensitivity
o Stress
o Change in nervous system communication between
the GI and brain
o Alteration in GI motility
o 10% IBS Cases are due to the Gastroenteritis Infection
6. Symptoms of IBS
Symptoms include :
- Change in bowel habit
- Often alternating constipation
and diarrhea
- Abdominal bloating and discomfort
- Sometimes abdominal pain
- Feeling of incomplete defecation
7. Role of Nutraceuticals In IBS
1. Aloe Vera
Anticancer
Detoxification
Wound healing
Diabetes and cardiovascular diseases
Cleansing agent
Reduce Pain